top of page
tokers-guide-find-the-best-weed-in-dc-lo
NEW 1 to 1 photo editing 122024 (17).png
House Republicans are advancing a funding bill aimed at blocking the federal rescheduling of marijuana despite moves by the Trump administration to reclassify it. The legislation also includes updated provisions to protect state-authorized medical cannabis and hemp research programs from federal interference.

The Resistance: GOP Lawmakers Still Fighting To Halt The Shift Toward Reclassification Despite Support From The Top

Apr 29, 2026

Source:

Tom Angell

Marijuana Moment

Federal progress on cannabis reform is hitting a snag on Capitol Hill as some House Republicans move to block the shift toward rescheduling. Despite the Trump administration’s recent announcement that it is moving ahead with reclassification, a powerful congressional subcommittee has introduced a funding bill designed to pull the plug on that momentum. Specifically, a new provision would prevent any federal funds from being used to carry out the rescheduling process, essentially trying to freeze the plant in its current restrictive status.

This kind of political pushback isn't exactly new, as similar language has been proposed in previous years without becoming law. However, it creates a confusing landscape for enthusiasts and business owners alike. Just last week, the Department of Justice cleared the way for state-licensed medical cannabis and FDA-approved products to move immediately to Schedule III. While this legislative attempt seeks to stall broader changes, it’s worth noting that the same bill actually includes several wins for the community.

For instance, the legislation maintains a long-standing protection that keeps the feds from interfering with state-legal medical marijuana programs. This year, Nebraska was finally added to that protected list, acknowledging the state's 2024 vote to legalize. There’s also continued protection for hemp research programs, which is a relief for those following the recent uncertainty surrounding hemp-derived cannabinoids.

So, why does this matter to the average consumer? It’s a reminder that while the executive branch is taking massive leaps toward accessibility and tax relief for the industry, the legislative path remains a bit of a maze. For now, the most important thing for enthusiasts to do is stay informed about their local laws and continue supporting the licensed dispensaries that are finally seeing a bit of federal daylight. Progress is definitely happening, even if there are a few more hurdles to clear in D.C. before the finish line.

Recent Reviews

bottom of page